DAIHAN Scientific Balance Sheet Health
Financial Health criteria checks 6/6
DAIHAN Scientific has a total shareholder equity of ₩49.3B and total debt of ₩1.5B, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are ₩62.1B and ₩12.8B respectively. DAIHAN Scientific's EBIT is ₩4.3B making its interest coverage ratio -33. It has cash and short-term investments of ₩8.1B.
Key information
3.0%
Debt to equity ratio
₩1.47b
Debt
| Interest coverage ratio | -33x |
| Cash | ₩8.12b |
| Equity | ₩49.29b |
| Total liabilities | ₩12.76b |
| Total assets | ₩62.05b |
Recent financial health updates
No updates
Recent updates
Does DAIHAN Scientific (KOSDAQ:131220) Deserve A Spot On Your Watchlist?
Apr 12
A Look At The Fair Value Of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
Mar 29The DAIHAN Scientific (KOSDAQ:131220) Share Price Has Gained 173%, So Why Not Pay It Some Attention?
Mar 11Shareholders Are Loving DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) 0.4% Yield
Feb 18We Like These Underlying Trends At DAIHAN Scientific (KOSDAQ:131220)
Jan 24
What Type Of Shareholders Own The Most Number of DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) Shares?
Dec 27DAIHAN Scientific Co., Ltd.'s (KOSDAQ:131220) Stock Is Going Strong: Is the Market Following Fundamentals?
Nov 30Is DAIHAN Scientific Co., Ltd. (KOSDAQ:131220) A Good Fit For Your Dividend Portfolio?
Jul 14Financial Position Analysis
Short Term Liabilities: A131220's short term assets (₩42.7B) exceed its short term liabilities (₩11.9B).
Long Term Liabilities: A131220's short term assets (₩42.7B) exceed its long term liabilities (₩850.0M).
Debt to Equity History and Analysis
Debt Level: A131220 has more cash than its total debt.
Reducing Debt: A131220's debt to equity ratio has reduced from 5% to 3% over the past 5 years.
Debt Coverage: A131220's debt is well covered by operating cash flow (221.2%).
Interest Coverage: A131220 earns more interest than it pays, so coverage of interest payments is not a concern.